PATHALYS Trademark

Trademark Overview


On Friday, December 15, 2023, a trademark application was filed for PATHALYS with the United States Patent and Trademark Office. The USPTO has given the PATHALYS trademark a serial number of 98316319. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 22, 2024. This trademark is owned by Pathalys Pharma, Inc.. The PATHALYS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for treating hemodialysis patients; calcimimetics in the nature of pharmaceuticals that mimic the action of calcium on tissues; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-sensing receptors on cells and managing calcium levels in the body

Research and development in the fields of pharmaceuticals, and nephrology, diseases, disorders, and conditions of the kidneys; Providing medical scientific research information in the fields of nephrology, diseases, disorders, and conditions of the kidneys, and pharmaceuticals.
pathalys

General Information


Serial Number98316319
Word MarkPATHALYS
Filing DateFriday, December 15, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for treating hemodialysis patients; calcimimetics in the nature of pharmaceuticals that mimic the action of calcium on tissues; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-sensing receptors on cells and managing calcium levels in the body
Goods and ServicesResearch and development in the fields of pharmaceuticals, and nephrology, diseases, disorders, and conditions of the kidneys; Providing medical scientific research information in the fields of nephrology, diseases, disorders, and conditions of the kidneys, and pharmaceuticals.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePathalys Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27609

Party NamePathalys Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27609

Trademark Events


Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Sunday, March 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 16, 2024ASSIGNED TO EXAMINER
Friday, July 19, 2024EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2024EXAMINER'S AMENDMENT ENTERED
Friday, July 19, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT